HALO logo
halo search icon
Alkermes Public Limited Company

US$36.98

Price Change Indicator
-0.02 (-0.054%)
Alkermes Public Limited Company
ALKS · NAS

Alkermes Public Limited Company

Start Trading ALKS for Free

US$36.98

Price Arrow-0.02 (-0.054%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusDefying GravityHALO AllHALO Price MomentumHammer BearishHammer Bearish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Alkermes Public Limited Company Overview

ALKS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Neutral

About ALKS

icon
icon

Telephone

353.1.772.8000

icon

Address

1 Burlington Road, Connaught House, Dublin 4

Description

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.

ALKS Price Chart

Key Stats

Market Cap

US$6.17B

PE

19.50

EV/EBITDA

12.1

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 25.17 - 39.56

Trade Value (12mth)

US$16,233,481.00

1 week

-1.28%

1 month

10.38%

YTD

30.93%

1 year

21.19%

All time high

75.03

Key Fundamentals

EPS 3 yr Growth

-251.80%

EBITDA Margin

19.00%

Operating Cashflow

$521m

Free Cash Flow Return

30.50%

ROIC

14.10%

Interest Coverage

22.90

Quick Ratio

3.20

Other Data

Shares Outstanding (Fully Diluted)

166m

HALO Sector

Healthcare

Next Company Report Date

17-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ALKS Announcements

Latest Announcements

DateAnnouncements
21 May 26
21 May 26
12 May 26
12 May 26
06 May 26

ALKS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock2.142.221.47locklocklock
EPS (Fully Diluted)
 $locklocklocklock2.12.171.43locklocklock
Growth
 %locklocklocklock321.43.7-33.9locklocklock
PE
 Xlocklocklocklock13.213.319.5locklocklock
EV/EBITDA
 Xlocklocklocklock8.69.212.1locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Alkermes Public Limited Company (ALKS:NAS)?
Halo FAQ
The current share price of Alkermes Public Limited Company (ALKS:NAS) is USD$36.98.
What is the 52-week high share price for Alkermes Public Limited Company (ALKS:NAS)?
Halo FAQ
The 52-week high share price for Alkermes Public Limited Company (ALKS:NAS) is USD$39.56.
What is the 52-week low share price for Alkermes Public Limited Company (ALKS:NAS)?
Halo FAQ
The 52-week low share price for Alkermes Public Limited Company (ALKS:NAS) is USD$25.17.
What is the dividend yield for Alkermes Public Limited Company (ALKS:NAS)?
Halo FAQ
Alkermes Public Limited Company (ALKS:NAS) does not pay a dividend.
What was Alkermes Public Limited Company (ALKS:NAS) last dividend payment?
Halo FAQ
Alkermes Public Limited Company (ALKS:NAS) does not pay a dividend.
What is the franking level for Alkermes Public Limited Company (ALKS:NAS)?
Halo FAQ
Alkermes Public Limited Company (ALKS:NAS) has a franking level of 0.00%.
In which sector is Alkermes Public Limited Company (ALKS:NAS) classified?
Halo FAQ
Alkermes Public Limited Company (ALKS:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Alkermes Public Limited Company (ALKS:NAS)?
Halo FAQ
The current P/E ratio for Alkermes Public Limited Company (ALKS:NAS) is 19.50.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial